Kkr & Co Inc Stock Price, News & Analysis

Ajax Health, backed by KKR, has announced the formation of FlowMod, a new collaboration with Boston Scientific to develop a heart failure treatment system. The initiative aims to accelerate development, clinical validation, and regulatory approval for treating a condition affecting 64 million people worldwide.

FlowMod will be led by CEO Dr. Philippe Marco, former President and COO of Epix Therapeutics and CV Ingenuity. The venture is supported by KKR's Health Care Strategic Growth Fund II, a $4.0 billion fund focused on high-growth healthcare companies. The platform will utilize intellectual property developed by Boston Scientific to create a differentiated solution for physicians and patients in heart failure treatment.

KKR, a global investment firm, has announced a bespoke financing solution for Family Doctor, one of Australia's leading GP clinic networks. The financing will enable Family Doctor to accelerate its growth and expansion plans while maintaining its 100% doctor-owned status.

Founded in 2008, Family Doctor operates more than 110 GP-run clinics across key metropolitan and regional areas in Australia, including Victoria, Queensland, Western Australia, New South Wales, the Australian Capital Territory, and South Australia.

The investment comes from KKR's Asia Pacific Credit strategy, which has completed over 50 credit investments in Asia Pacific since 2019, with total transaction value approaching US$21 billion. This partnership will allow Family Doctor to leverage KKR's global network and expertise while pursuing its mission of providing quality healthcare services.

FS KKR Capital Corp. (FSK) has announced its Q4 and full-year 2024 results, along with declaring a Q1 2025 distribution of $0.70 per share. The Q4 results show net investment income of $0.61 per share, down from $0.77 in Q3 2024. The company's net asset value decreased to $23.64 per share from $23.82 in Q3 2024.

For the full year 2024, FSK reported net investment income of $2.90 per share compared to $3.18 in 2023. The investment portfolio totaled $13.5 billion, with 63.8% invested in senior secured securities. The weighted average annual yield on accruing debt investments was 11.3%, down from 11.9% in Q3 2024.

The company maintains a strong liquidity position with $4.8 billion available and a net debt to equity ratio of 104%. Non-accrual investments represented 2.2% of the portfolio at fair value, up from 1.7% in Q3 2024.

KKR has announced the acquisition of a controlling stake in Healthcare Global Enterprises (HCG), India's leading oncology hospital chain. KKR will acquire up to 54% equity from CVC Asia V at INR 445 per share, with potential ownership between 54-77% following an open offer to public shareholders. The deal values at approximately $400 million.

Founded in 1989, HCG operates 25 medical centers across 19 Indian cities, featuring 2,500 beds, nearly 100 operating theaters, and 40 linear accelerator machines. Dr. BS Ajaikumar, HCG's founder, will transition to Non-Executive Chairman, focusing on clinical excellence and R&D.

The transaction, funded through KKR's Asia Fund IV, is expected to close by Q3 2025, subject to regulatory approvals. This marks KKR's latest investment in India's healthcare sector, following investments in Baby Memorial Hospital, Healthium, Infinx, Max Healthcare, JB, and Gland Pharma.

KKR has announced its first residential investment in Stockholm through a forward-purchase agreement with Swedish developers Reliwe and The Derome Group for three multifamily properties in Haninge. The development comprises 382 residential units, expected for completion between late 2026 and early 2027.

The project includes two timber construction properties built by Derome and one traditional concrete construction asset. Located near a bus terminal and railway station, the development aims to deliver affordable modern urban living with premium amenities while meeting high environmental standards.

Over the past two years, KKR has committed approximately $550 million (SEK 6 billion) to Nordic real estate investments. The company will work with local operating partner Cavendo to manage and grow the Stockholm residential platform.

KKR has successfully completed its tender offer for FUJI SOFT, becoming the largest shareholder with a 57.92% ownership stake. The second stage of the tender offer concluded on February 19, 2025, with settlement scheduled for February 27, 2025. KKR plans to acquire the remaining shares through a squeeze-out process, aiming for 100% ownership, with an Extraordinary General Meeting planned for late April 2025.

FUJI SOFT, a leading Japanese system integration company with over 10,000 system engineers, achieved record-high performance in FY2024 with revenue of 317.5 billion yen and operating income of 22 billion yen (6.5% margin). The tender offer process was extended by four months due to a competing proposal from Bain Capital. The acquisition will be primarily financed through KKR Asian Fund IV.

KKR has announced a strategic partnership with EGC, a German energy service provider based in Düsseldorf. EGC manages approximately 2 million square meters of real estate for over 100 clients and operates around 800 central heating units. The founding family will retain ownership stake and remain active in management, while Michael Lowak joins as Chairman.

The partnership aims to transform EGC into the leading decarbonization partner for the real estate industry in Germany. EGC provides comprehensive energy services, from planning and developing concepts for energy systems to financing and operating heating units and electricity networks.

KKR will implement its employee ownership model, previously successful across 60 portfolio companies. The investment firm brings significant infrastructure expertise, managing approximately USD 77 billion in infrastructure assets, including USD 21 billion in energy transition investments. The deal is funded through KKR's Global Climate Strategy, focusing on low-carbon economy solutions.

KKR has announced the acquisition of a stake in Employment Hero from SEEK Investments, with SEEK Growth Fund remaining a material investor. Founded in 2014, Employment Hero is a leading employment management platform serving over 300,000 SMEs globally with HR management, payroll, recruitment, and employee engagement tools.

The company has achieved A$250 million in annual recurring revenue (ARR) and recently acquired Canadian platform Humi in January. The transaction, expected to complete by Q1 2025, marks KKR's latest technology growth investment in Australia through its Asia Next Generation strategy.

Employment Hero plans to focus on international expansion and platform development, leveraging KKR's experience and network. The investment follows KKR's previous growth equity investments in the region, including Advanced Navigation, SmartHR, GrowSari, KiotViet, and Privy.

KKR has announced the final close of its KKR Opportunistic Real Estate Credit Fund II (ROX II), securing over $850 million in commitments. The fund focuses on opportunistic investments in senior loans and real estate securities across the U.S. and Western Europe.

The strategy will pursue first mortgages secured by high-quality properties owned by institutional sponsors in major markets. KKR's position as the largest third-party purchaser of risk retention CMBS B-Pieces and its dedicated special servicer, K-Star, will support securities investments.

Since 2015, KKR's real estate credit strategy has originated $43.4 billion of loans and invested $14 billion in commercial mortgage-backed securities. The firm's global real estate business employs over 140 dedicated investment and asset management professionals across 16 offices.